Article

Plasmablastic lymphoma in the ileum


 

Plasmablastic lymphoma (PBL) is classified by the World Health Organization as a distinct type of diffuse large B-cell non-Hodgkin lymphoma, which is characterized by plasma cell differentiation and immunoblastic cell morphology.1 PBL usually develops in middle-aged adults, with the age at onset in one large series ranging from 35 to 55 years with male predominance.2-4 Although PBL has a strong affinity for the oral cavity, especially in HIV-positive patients, extraoral sites have also been reported.5-10 In this report, we describe an unusual case of PBL presented as multiple masses mostly located at the ileum, which resulted in small bowel obstruction.

*Click on the link to the left for a PDF of the full article.

Recommended Reading

TOPPS: Limit prophylactic platelets to select groups
MDedge Hematology and Oncology
MLN9708 regimen effective with reduced neuropathy risk in multiple myeloma
MDedge Hematology and Oncology
Live from ASH: Dr. David Henry shares his 'did you know' picks
MDedge Hematology and Oncology
Did you know: Dr. David Henry reports from ASH
MDedge Hematology and Oncology
Lenalidomide branches out to lymphoma therapy
MDedge Hematology and Oncology
Transplants don't boost overall survival in high-risk DLBCL
MDedge Hematology and Oncology
PET projects treatment response in adult Hodgkin's disease
MDedge Hematology and Oncology
FDA approves generic doxorubicin to address shortage
MDedge Hematology and Oncology
FDA approves pomalidomide for advanced multiple myeloma
MDedge Hematology and Oncology
Company suspends enrollment in drug trials
MDedge Hematology and Oncology